The observer-blind, randomised controlled study to determine the safety and immunogenicity of “Covishield” on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.
Read more here:: India News Times
Follow Our Network On LinkedIn: Follow link
Search India recent news in rumors and anything online listing
The observer-blind, randomised controlled study to determine the safety and immunogenicity of “Covishield” on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.
Read more here:: India News Times